Generalized Anxiety Disorder: From Science to ArtHagop S. Akiskal, Elie Hantouche, Lewis L. Judd |
From inside the book
Results 1-3 of 17
Page 9
... variables : ( i ) ' seek- ing psychiatric out - patient treatment ' and ( ii ) ' any serious and ongoing tensions ... variable ' ' any serious and ongoing tensions , conflicts or arguments with others ' , in which 30 % of the ' GAD alone ...
... variables : ( i ) ' seek- ing psychiatric out - patient treatment ' and ( ii ) ' any serious and ongoing tensions ... variable ' ' any serious and ongoing tensions , conflicts or arguments with others ' , in which 30 % of the ' GAD alone ...
Page 59
... variables of Conscientiousness , Agreeableness and Openness to Neuroticism and Extraversion , have been exten- sively studied , showing roughly 30-60 % herita- bility ( 2 , 5 , 59 ) . Neuroticism is viewed as a superfactor continuous ...
... variables of Conscientiousness , Agreeableness and Openness to Neuroticism and Extraversion , have been exten- sively studied , showing roughly 30-60 % herita- bility ( 2 , 5 , 59 ) . Neuroticism is viewed as a superfactor continuous ...
Page 97
... variables associated with more severe with- drawal , and unsuccessful taper off the drug , may be divided , for the sake of discussion , into drug variables and clinical variables These variables have been identified over the past 10 ...
... variables associated with more severe with- drawal , and unsuccessful taper off the drug , may be divided , for the sake of discussion , into drug variables and clinical variables These variables have been identified over the past 10 ...
Contents
H S Akiskal L L Judd | 2 |
Comorbidity as a fundamental feature of 6 L L Judd R C Kessler M P Paulus | 12 |
On the one aspect of generalized anxiety 30 V Davtian | 32 |
Copyright | |
6 other sections not shown
Common terms and phrases
Acta action activity agents agonists animal antidepressants anxiety disorder anxiolytic anxious appear Arch Gen Psychiatry associated BARLOW behavior benzodiazepine buspirone changes chronic Clin clinical cognitive comorbid compared comparison criteria dependence diagnostic disturbance drug early effects efficacy emotional et al expectations experience factors fear function GAD patients genetic half-life heart human hydroxyzine increased individuals interview less levels lifetime long-term major depression measures medication ment mental months mood nature object observed onset panic disorder patients personality personality disorders phobia physiological placebo population present Press prevalence problems processes Psychiatry psychological psychopathology receptor reduced References relationship reported response risk score severity showed sleep social somatic specific stress subjects suggest symptoms syndrome Table temperament tension term therapy tion traits treat treatment trial variables weeks withdrawal worry York